Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Examining impacts of approval of home use of misoprostol in England on access to medical abortion

View ORCID ProfileMaria Lewandowska, Daniel J Carter, View ORCID ProfilePatricia A. Lohr, Kaye Wellings
doi: https://doi.org/10.1101/2022.03.28.22273043
Maria Lewandowska
1Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Lewandowska
Daniel J Carter
1Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia A. Lohr
2Centre for Reproductive Research & Communication, British Pregnancy Advisory Service, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patricia A. Lohr
Kaye Wellings
1Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaye.wellings{at}lshtm.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2022.03.28.22273043
History 
  • March 31, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Maria Lewandowska*,1,
  2. Daniel J Carter*,1,
  3. Patricia A. Lohr2 and
  4. Kaye Wellings**,1
  1. 1Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine
  2. 2Centre for Reproductive Research & Communication, British Pregnancy Advisory Service, UK
  1. ↵**corresponding author email: kaye.wellings{at}lshtm.ac.uk
  1. Author contributions ML, DC, PL, and KW conceptualized the study. ML coordinated the ethical approvals and conducted the preliminary analyses. DC conducted the final analyses. ML & DC wrote the first draft. All authors contributed to the final manuscript.

Back to top
PreviousNext
Posted March 31, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Examining impacts of approval of home use of misoprostol in England on access to medical abortion
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Examining impacts of approval of home use of misoprostol in England on access to medical abortion
Maria Lewandowska, Daniel J Carter, Patricia A. Lohr, Kaye Wellings
medRxiv 2022.03.28.22273043; doi: https://doi.org/10.1101/2022.03.28.22273043
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Examining impacts of approval of home use of misoprostol in England on access to medical abortion
Maria Lewandowska, Daniel J Carter, Patricia A. Lohr, Kaye Wellings
medRxiv 2022.03.28.22273043; doi: https://doi.org/10.1101/2022.03.28.22273043

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Sexual and Reproductive Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)